Ortec International said Tuesday (20th June) the European patent office has granted the firm a patent on its Fibrin Microbead technology for isolating certain types of adult stem cells. The technology has previously been granted five U.S. patents.

The Fibrin technology is a proprietary matrix for isolating, expanding and differentiating Mesenchymal-type adult stem cells, a process that could be useful for using the cells to treat patients.

Link [www.upi.com/HealthBusiness/view.php?StoryID=20060620-092242-4860r]